ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352741 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352741; 2) Community: the network communities that were significantly associated with the response to NSC 352741; 3) Molecule: the relationships between components within communities and NSC 352741; 4) MDR: the compounds that were significantly associated with the NSC 352741.

NSC Compound Enrichment Correlation
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0459335986102865 0.28895986
NSC 200692 Aspiculamycin hydrochloride 0.0459335986102872 -0.22028374
NSC 682298 Camptothecin Derivative 0.0462077035966078 0.24024521
NSC 683605 Null 0.0462077035966078 0.27399815
NSC 117281 ANTINEOPLASTIC-117281 0.0462077035966081 0.23077557
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.0462077035966081 0.40912935
NSC 23416 Null 0.0462077035966081 0.39413792
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.0462077035966081 0.36130726
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0462077035966084 0.53582368
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.0462077035966084 0.49663049
Total:89  Current:81    [First] [Prev] [Next] [Last]